HomeAQS • CVE
add
Aequus Pharmaceuticals Inc
Previous close
$0.0050
Day range
$0.0050 - $0.0050
Year range
$0.0050 - $0.040
Market cap
663.17K CAD
Avg Volume
51.06K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 148.32K | 1,010.26% |
Operating expense | 623.38K | -19.55% |
Net income | -614.73K | 23.51% |
Net profit margin | -414.46 | 93.11% |
Earnings per share | — | — |
EBITDA | -546.48K | 29.05% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.41K | -77.32% |
Total assets | 858.02K | -26.78% |
Total liabilities | 7.08M | 48.75% |
Total equity | -6.22M | — |
Shares outstanding | 132.63M | — |
Price to book | -0.10 | — |
Return on assets | -146.71% | — |
Return on capital | -304.13% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -614.73K | 23.51% |
Cash from operations | -348.70K | 46.33% |
Cash from investing | — | — |
Cash from financing | 330.02K | -54.88% |
Net change in cash | -18.67K | -122.87% |
Free cash flow | -133.11K | 63.77% |
About
Founded
2013
Headquarters
Website
Employees
12
